CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Kalbe Farma Tbk PT is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Kalbe Farma Tbk PT
Gedung KALBE Let.Jend Suprato Kav. 4
Phone: +62 2142873888p:+62 2142873888 JAKARTA PUSAT, 10510  Indonesia Ticker: KLBFKLBF
Business Summary
PT Kalbe Farma Tbk is an Indonesia-based company, which is engaged in the development, manufacturing and trading of pharmaceutical products including human medicines and consumer health products. Its business divisions include Prescription Pharmaceutical, Consumer Health Division, Nutritionals, and Distribution and Logistic divisions. The Prescription Pharmaceuticals division provides a range of products for all groups, from unbranded generic drugs for the mass-market segment, to branded generics and licensed drugs. The Consumer Health division's product portfolio spans from over the counter (OTC) drugs and energy drinks to a selection of ready-to-drink healthy beverage products. The Nutritional division manages a range of nutritional products, comprising of powdered milk products for all age segments. It also offers a selection of non-milk nutritional products. The Distribution and Logistics Division operates the distribution coverage for pharmaceuticals products in Indonesia.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
5122 Drugs, drug proprietaries, and druggists' sundries
2023 Dry, condensed, and evaporated dairy products
5047 Medical, dental, and hospital equipment and supplies

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President Commissioner Bernadette Ruth IrawatiSetiady 62 6/5/2017 1/1/1997
President Director ..Vidjongtius 59 1/1/2022 1/1/1997
Director Mulialie.. 54 5/27/2021 5/27/2021
8 additional Officers and Directors records available in full report.

Business Names
Business Name
Bintang Toejoe
KLBF
P.T. Kalbe Farma Tbk
PT Kalbe Farma Tbk
PT Saka Farma Laboratories

General Information
Number of Employees: 12,924 (As of 9/30/2024)
Outstanding Shares: 46,149,181,210 (As of 9/30/2024)
Shareholders: 1,298
Stock Exchange: JAK
Fax Number: +62 214256326


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024